Picture of Soligenix logo

SNGX Soligenix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Soligenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.36-17.7-12.6-13.8-6.14
Depreciation
Non-Cash Items0.6555.660.1260.70.968
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1.140.5090.6510.425-3.44
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-7.51-11.5-11.7-12.6-8.6
Capital Expenditures-0.03-0.007-0.012-0.013
Purchase of Fixed Assets
Other Investing Cash Flow Items0.005
Sale of Fixed Assets
Cash from Investing Activities-0.025-0.007-0.012-0.013
Financing Cash Flow Items-0.132-0.798-0.667-0.003-0.927
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.0124.719.10.0773.66
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.5613.37.37-12.7-4.91